Closed System Transfer Devices Market Size, Share, Status and Prospects 2022 to 2032

The global Closed System Transfer Devices market was worth USD 872 million in 2022, and it is expected to grow at an 18.1% CAGR over the forecast period to reach USD 3800 million by 2032.

A closed system transfer device, also known as a 'CSTD,' is a drug transfer device that mechanically restricts the transfer of environmental contamination within the medical system as well as the escape of hazardous drug or vapour concentrations outside the system. To maintain the sterility of a fluid pathway, open versus closed systems are commonly used in medical devices. CSTDs prevent the uncontrolled inflow and outflow of contaminants and drugs, thereby preserving the quality of the solution to be infused into a patient. These devices protect healthcare workers when they are exposed to hazardous drugs or chemicals.

In recent years, closed system transfer device designs and models have changed at a rapid pace, resulting in the development of a number of independent testing methodologies to assess closed system transfer device performance. Manufacturers in the closed system transfer devices market are currently focusing more on meeting performance requirements, which are primarily concerned with patient safety and sterile practises.

Market trends and drivers: Include the increasing use of CSTDs to combat the harmful effects of cytotoxic and antineoplastic drugs. Antineoplastic drugs are widely used in cancer treatment and are considered dangerous drugs. Healthcare workers who prepare, transport, distribute, administer (pre and post-administration), and dispose of these drugs are extremely vulnerable.

The National Institute for Occupational Safety and Health (NIOSH) recommends using CSTDs to eliminate the harmful effects caused by hazardous substances that escape from the system during drug preparation and administration. CSTDs act as a barrier, preventing contaminants from being transferred from the atmosphere to a sterile environment. Because of these benefits, CSTDs are increasingly being used in healthcare facilities to combat the negative effects of dangerous drugs. Chemotherapy, a popular cancer treatment, employs one or more antineoplastic drugs to kill abnormal cells in patients. When preparing, transporting, administering, and disposing of hazardous drugs, the use of closed system transfer devices (CSTDs) in conjunction with other safety precautions such as gloves, gowns, masks, and vented preparation hoods is an effective way to increase safety. With the rising prevalence of cancer and the increased use of chemotherapy treatments, the demand for CSTDs is expected to rise in the coming years.

COVID-19 Impact: The COVID-19 outbreak reduced demand for CSTDs during the first two quarters of 2020. Due to virus containment norms and nationwide lockdowns, hospital patient footfalls were limited, primarily due to COVID-19 and emergency cases. Elective medical procedures are on hold, causing a downward shift in demand for CSTDs. Nonetheless, with the decline in the number of active COVID-19 cases and the economic recovery in developed countries, more use of these devices may be expected in the near future.

B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd, Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd. (JMS Co Ltd.), and Yukon Medical are the key players in the closed system transfer devices market.

Browse More@ https://www.futuremarketinsights.com/reports/closed-system-transfer-devices-market

Comments

Post a Comment

Popular posts from this blog

Portable Oxygen Concentrators Market | Innovative and Technological Advancement

Image
The global  portable oxygen concentrators market  is anticipated to witness lucrative growth opportunities over the forecast period from 2022 and 2032, with a phenomenal CAGR of 10.1%. The market is expected to enjoy a valuation of US$ 1.9 Billion by the end of the year 2022 and surpass a projection of US$ 5.0 Billion by the year 2032. According to the Future Market Insights historical analysis, the pulse flows portable oxygen concentrators were leading the market with a share of about 67.7% in the year 2021, within the global market. In the year 2021, the market value for portable oxygen concentrators was around 54.8% of the overall US$ 3.5 Billion of the global oxygen concentrators market. Portable oxygen concentrators supply oxygen to those patients who are suffering from respiratory diseases such as chronic obstructive pulmonary disease. In this process, nitrogen and oxygen are separated from the air in the environment with the help of the concentrator which then discards ...
Read more

Helicobacter Pylori Infections Treatment Market Research and Analysis 2023 to 2033

Image
The global helicobacter pylori infections treatment market is predicted to reach US$ 638.3 Million in 2023, with a compound annual growth rate (CAGR) of 7.04% anticipated from 2023 to 2033, reaching US$ 1,260 Million. The spread of such infections can be attributed to a number of factors, including a lack of adequate water supply, poor sanitation, a large population, and poor personal hygiene. One of the factors influencing the Helicobacter pylori diagnostics market's growth is increased awareness of H. pylori infections in the cohort. Antibiotic availability and affordability, as well as quicker processing times, will boost antibiotic use and the need for pre and post-surveillance tests. Furthermore, rising H. pylori infection rates, the need for early symptom diagnosis, and technological advances in diagnostic methods are expected to fuel overall growth over the forecast period. The key drivers of the industry are the increasing prevalence of communicable diseases and rising pub...
Read more

Pediatric Clinical Trials Market size is set to Grow at a Remarkable Pace by 2032

Image
During the forecast period 2022 to 2032, the global pediatric clinical trials market  is expected to grow at a value of 5.3%, according to Future Market Insights. In 2022, this market was predicted to have a global valuation of US$ 15.8 Billion, and is expected to reach a sum of US$ 26.47 Billion by 2032. The market is going to face increasing demand owing to the increase of pediatric chronic and genetic diseases all across the world. The growing need for novel vaccines and biopharmaceuticals to treat infectious diseases such as measles, polio, tuberculosis, rubella, influenza, mumps, whooping cough, malaria, chickenpox, and staphylococcus pharyngitis is expected to drive market growth. At the same time, diabetes is a big worry among today's children. The market is being driven by rising parental awareness of children clinical trials for severe infections and chronic diseases, as well as a large number of CROs doing pediatric research. In 2021, the onc...
Read more